| 000 | 01586 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513192058.0 | ||
| 264 | 0 | _c19990922 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0033-3549 | ||
| 024 | 7 |
_a10.1093/phr/114.3.269 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoore, M | |
| 245 | 0 | 0 |
_aCross-matching TB and AIDS registries: TB patients with HIV co-infection, United States, 1993-1994. _h[electronic resource] |
| 260 |
_bPublic health reports (Washington, D.C. : 1974) _c |
||
| 300 |
_a269-77 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xepidemiology |
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xepidemiology |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntitubercular Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPopulation Surveillance |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 |
_aRifampin _xtherapeutic use |
| 650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xdrug therapy |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 700 | 1 | _aMcCray, E | |
| 700 | 1 | _aOnorato, I M | |
| 773 | 0 |
_tPublic health reports (Washington, D.C. : 1974) _gvol. 114 _gno. 3 _gp. 269-77 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/phr/114.3.269 _zAvailable from publisher's website |
| 999 |
_c10434443 _d10434443 |
||